Bienvenu, Anne-Lise
Duffour, Alexandra
Chatron, Claire
Mrozek, Natacha
Foroni, Luc
Millet, Aurélien
Lukaszewicz, Anne-Claire
Merveilleux-du-Vignaux, Claire
Portran, Philippe
Parant, François
Vial, Thierry
Labussière-Wallet, Hélène
Moluçon-Chabrot, Cécile
Rascle, Pauline
Henry, Agnès
Pradat, Pierre
Goutelle, Sylvain https://orcid.org/0000-0002-1853-2932
Funding for this research was provided by:
Hospices Civils de Lyon
Article History
Accepted: 2 March 2025
First Online: 28 March 2025
Declarations
:
: Open access funding provided by Hospices Civils de Lyon.
: Sylvain Goutelle is an Editorial Board member of Clinical Drug Investigation. Sylvain Goutelle was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions
: This was a non-interventional study with no additional procedure. Data were collected during routine patient care. This study was conducted in accordance with the Declaration of Helsinki and national and institutional standards. This study was approved as an evaluation of professional practices by the Quality department of Lyon university hospital.
: Due to the retrospective nature of the study, formal consent was not required. Electronic records were under the auspice of the French National Committee for Data Protection and Freedom of Information (N°23–138).
: Not applicable.
: The data that support the findings of this study are not openly available due to protect study participant privacy.
: Not applicable.
: ALB, SG, and LF, designed the work. AD, AH, ALB, CC, CM, CMC, HLW, NM, PP, PR, and ACL, contributed to data acquisition. ALB, AM, FP, PP, SG, and TV, contributed to data analysis. ALB and AD wrote the original draft. All authors reviewed the manuscript critically and approved the final version. All authors agreed to be accountable for all aspects of the work.